Search
Canopy Growth Corp
CGCAdd to Watchlist
0.946USD
0.0000.00%
Close 06/26, 16:00（ET）Quotes delayed by 15 min
399.23MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-2.20%
1 Month
-11.60%
6 Months
-20.51%
Year to Date
-17.03%
1 Year
-22.47%
Key Figures
--Open
0.000High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
1.20%Turnover Ratio
0.946Prev. Close
0.000Low
0.00Turnover
LossP/E Static
0.80P/B
0.00%Div Yield TTM
-28.83%ROA
3.28052wk High
1.40Volume Ratio
-598.12MNet Profit
422.07MShares
-1.3551EPS TTM
2.42Beta
-48.50%ROE
1.18052wk Low
3.93%Amplitude
11.60%Gross Margin
399.23MMarket Cap
-3.03Reward/Risk
5.36%Risk Rate
TradingKey Stock Score of Canopy Growth Corp
Currency: USD Updated: 2026-06-26Key Insights
Canopy Growth Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 107 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 1.22.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Canopy Growth Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Canopy Growth Corp Highlights
StrengthsRisks
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
Fairly Valued
The company’s latest PE is -0.70, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 46.90M shares, increasing 9.85% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.56.
Analyst Rating
Based on
3
analysts
Hold
Current Rating
1.220
Target Price
+33.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Canopy Growth Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Canopy Growth Corp Info
Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
Ticker SymbolCGC
CompanyCanopy Growth Corp
CEOMongeau (Luc)
Websitehttps://www.canopygrowth.com/
Related Instruments
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%Popular Instruments
FAQs
What is the current price of Canopy Growth Corp (CGC)?
The current price of Canopy Growth Corp (CGC) is 0.95.
What is the symbol of Canopy Growth Corp?
The ticker symbol of Canopy Growth Corp is CGC.
What is the 52-week high of Canopy Growth Corp?
The 52-week high of Canopy Growth Corp is 3.28.
What is the 52-week low of Canopy Growth Corp?
The 52-week low of Canopy Growth Corp is 1.18.
What is the market capitalization of Canopy Growth Corp?
The market capitalization of Canopy Growth Corp is 417.01M.
Is Canopy Growth Corp (CGC) currently rated as Buy, Hold, or Sell?
According to analysts, Canopy Growth Corp (CGC) has an overall rating of signal_hold, with a price target of 1.22.
What is the Earnings Per Share (EPS TTM) of Canopy Growth Corp (CGC)?
The Earnings Per Share (EPS TTM) of Canopy Growth Corp (CGC) is -0.63.
